AMERISAFE, Inc. (NASDAQ:AMSF) Stock Rating Reaffirmed by B. Riley

B. Riley reissued their buy rating on shares of AMERISAFE, Inc. (NASDAQ:AMSF) in a report issued on Monday, November 6th. B. Riley also issued estimates for AMERISAFE’s FY2017 earnings at $3.30 EPS, FY2018 earnings at $3.20 EPS and FY2019 earnings at $3.10 EPS.

AMSF has been the subject of several other reports. Zacks Investment Research raised shares of AMERISAFE from a hold rating to a buy rating and set a $60.00 target price for the company in a research note on Friday, September 1st. SunTrust Banks, Inc. reaffirmed a buy rating and issued a $69.00 target price on shares of AMERISAFE in a research note on Friday, October 27th. Boenning Scattergood began coverage on shares of AMERISAFE in a research note on Monday, September 25th. They issued a neutral rating for the company. BidaskClub lowered shares of AMERISAFE from a buy rating to a hold rating in a report on Wednesday, July 12th. Finally, FBR & Co reiterated a buy rating on shares of AMERISAFE in a report on Wednesday, October 25th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company has an average rating of Buy and an average target price of $66.00.

Shares of AMERISAFE (NASDAQ AMSF) traded down $0.75 on Monday, hitting $64.65. 51,917 shares of the stock were exchanged, compared to its average volume of 85,682. AMERISAFE has a fifty-two week low of $51.20 and a fifty-two week high of $69.40. The stock has a market cap of $1,258.56, a PE ratio of 19.01 and a beta of 0.89.

AMERISAFE (NASDAQ:AMSF) last released its earnings results on Wednesday, October 25th. The insurance provider reported $0.87 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.79 by $0.08. The firm had revenue of $92.90 million during the quarter, compared to analysts’ expectations of $92.04 million. AMERISAFE had a net margin of 17.07% and a return on equity of 13.92%. AMERISAFE’s revenue for the quarter was down 5.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.93 EPS. analysts expect that AMERISAFE will post 3.22 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 28th. Shareholders of record on Thursday, December 14th will be issued a $0.20 dividend. The ex-dividend date is Wednesday, December 13th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.24%. AMERISAFE’s dividend payout ratio (DPR) is presently 23.81%.

In other AMERISAFE news, CFO Neal Andrew Fuller sold 1,850 shares of the business’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $56.94, for a total value of $105,339.00. Following the transaction, the chief financial officer now owns 23,210 shares in the company, valued at approximately $1,321,577.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO G. Janelle Frost sold 1,728 shares of the business’s stock in a transaction on Tuesday, November 7th. The stock was sold at an average price of $66.74, for a total transaction of $115,326.72. Following the completion of the transaction, the chief executive officer now owns 54,322 shares in the company, valued at approximately $3,625,450.28. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

A number of hedge funds have recently modified their holdings of AMSF. UBS Asset Management Americas Inc. acquired a new position in AMERISAFE in the 1st quarter worth $268,000. Parametric Portfolio Associates LLC increased its position in shares of AMERISAFE by 10.3% in the 1st quarter. Parametric Portfolio Associates LLC now owns 23,065 shares of the insurance provider’s stock worth $1,497,000 after purchasing an additional 2,149 shares during the last quarter. OppenheimerFunds Inc. increased its position in shares of AMERISAFE by 18.1% in the 1st quarter. OppenheimerFunds Inc. now owns 4,792 shares of the insurance provider’s stock worth $311,000 after purchasing an additional 736 shares during the last quarter. Teachers Advisors LLC increased its position in shares of AMERISAFE by 2.5% in the 1st quarter. Teachers Advisors LLC now owns 31,823 shares of the insurance provider’s stock worth $2,065,000 after purchasing an additional 788 shares during the last quarter. Finally, Legal & General Group Plc increased its position in shares of AMERISAFE by 0.3% in the 1st quarter. Legal & General Group Plc now owns 31,819 shares of the insurance provider’s stock worth $2,064,000 after purchasing an additional 93 shares during the last quarter. Hedge funds and other institutional investors own 98.38% of the company’s stock.

TRADEMARK VIOLATION WARNING: “AMERISAFE, Inc. (NASDAQ:AMSF) Stock Rating Reaffirmed by B. Riley” was originally published by BBNS and is the sole property of of BBNS. If you are reading this report on another publication, it was copied illegally and republished in violation of international copyright and trademark laws. The legal version of this report can be viewed at https://baseballnewssource.com/markets/b-riley-reiterates-buy-rating-for-amerisafe-inc-amsf/1761732.html.

About AMERISAFE

Amerisafe, Inc is an insurance holding company. The Company is engaged in providing workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, manufacturing, and agriculture. It is engaged in underwriting the workers’ compensation exposures inherent in these industries.

Receive News & Ratings for AMERISAFE Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.